Oleoyl Ethanolamide Phosphate (OEA-P) is primarily researched for its potential therapeutic applications, particularly in the fields of metabolism and inflammation. It is studied for its role in modulating lipid metabolism, which could be beneficial in managing conditions like obesity and metabolic syndrome. OEA-P is also explored for its anti-inflammatory properties, making it a candidate for treating inflammatory diseases. Additionally, its interaction with the endocannabinoid system suggests potential in regulating appetite and energy balance, which could be useful in developing treatments for eating disorders or metabolic dysregulation. Research is ongoing to fully understand its mechanisms and therapeutic potential.